3D-CANCER-SPEC is a new innoFSPEC transfer project as part of the EU ATTRACT initiative which recently started with a kick-off meeting at CERN in Geneva, Switzerland. 3D-CANCER-SPEC will bring astronomical technology to bear against cancer, one of the leading cause of death worldwide. This project — coordinated by Martin Roth of innoFSPEC at the Leibniz Institute for Astrophysics Potsdam — will combine the expertise of two partners involved in the development of the innovative MUSE instrument on ESO’s Very Large Telescope. By doing so, the team will carry out a design study for an imaging spectrograph suitable for clinical cancer studies.
You can watch Martin Roth's pitch about the project here.
ATTRACT, a Horizon 2020 research and innovation project funded by the European Union and backed by a consortium of 9 partners including ESO, has announced 170 breakthrough ideas which will each receive €100,000 to develop technologies that have the potential to change society. The kick-off meeting has started the clock on a one-year countdown for the selected proposals to prove the scientific merit and innovation potential of their disruptive detection and imaging technologies.
For more details please have a look at ESO’s full press release and visit the ATTRACT website.